FDA Inspection 1167983 — Ben Taub General Hospital Blood Bank
The FDA completed an inspection of Ben Taub General Hospital Blood Bank on March 18, 2022 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)